TRANSLATIONAL SCIENCE 2024

Thursday, April 21

See below activities from invited speakers scheduled for Thursday, April 21 during Translational Science 2022 in Chicago. All activities take place in the Central Daylight Time Zone (CDT) unless otherwise specified.

Select scientific sessions to be live streamed each day for those registered as a virtual attendee. These select sessions will only be available to watch live virtually during the scheduled session day/time. No sessions will be offered on-demand for any registration type at this time. Live stream sessions to be announced soon. Visit the Registration page for more details about the Translational Science 2022 virtual component.

Scientific Session Track Legend

Community Engagement     Core Activities     CR Forum     DEI     Translational Workforce Development + Education     Valued Approaches

Sessions noted as (Virtual + In Person) will be presented in person and available to watch in the meeting app for virtual only attendees.

 

8:00 - 9:30 AM
8:30 - 10:45 AM
  • Speed Mentoring Sessions*

    Core Activities | Translational Science 2022 will be hosting an hour-long speed mentoring session, with two time options for attendance. Speed mentoring allows mentees to connect with four senior scientists over the course of an hour for mini-discussions. Speed mentoring is a great way to expand your network, ask pointed questions, get advice about finding resources, seek candid feedback, and chat informally about life in research with people who know the ropes.

    *This session requires pre-registration.

9:45 - 10:45 AM
  • CR Forum Industry Roundtable: Engagement of Industry in Clinical Research

    Presenter: Anantha Shekhar, MD

    CR Forum | Clinical Research Forum’s Industry Roundtable focuses on inspiring dialogue and collaboration among academic health centers, industry leaders, researchers, and advocates to advance clinical and translational research. This session will focus on how industry is changing how clinical trials are done, by establishing innovative community partnerships directly to enroll patients. This new model has positive implications for health equity and rare disease research, but how should PI-directed academic health centers adapt as partners?  Hear the industry side of things from Eli Lilly, PhRMA, and Abbvie.

    Moderator/Panel Organizer: Carlos Garner, PhD, VP of Global Regulatory Affairs, Eli Lilly

    Panelists:

    Richard Moscicki, MD, Executive Vice-President of Science and Advocacy, PhRMA

    Roopal Thakkar, MD, Vice-President Global Regulatory Affairs, Abbvie

    Janelle Sabo, Pharm. D., GEMBA, Vice-President, Clinical Trial Capabilities, Eli Lilly and Company

  • Learning as the Ultimate Translational Science

    Presenters: Gaetano R. Lotrecchiano, EdD, PhD; Marie Norman, PhD; Lenore Corsino, MD, FACE, MHS; Katherine Guevara, DPPD; Evonne Kaplan-Liss, MD, MPH, FAAP

    Translational Workforce Development + Education | The learning sciences have yielded a wealth of insights about the mechanisms and conditions that promote learning, and this body of research has the potential to impact education effectiveness. This fundamentally translational opportunity is one we believe that educators from translational fields, with their evidence-based orientation and familiarity with the challenges and importance of translation, are well-positioned to provide. In this session, based on the Journal of Clinical and Translational Science Special Issues on Education (Gabrilove, Patino, and Ringold, eds.), presenters will provide an overview of learning research and its application to clinical and translational science education, offering examples of educational scholarship that focuses on timely issues: 1) educating for diversity, equity, and inclusion, 2) myths about online education, and 3) storytelling as a method for disseminating science. They willdescribe the unique teaching and learning environment in which this training occurs, and why it necessitates attention to learning research and its appropriate application; define the learning sciences; and explain, how principles from the learning sciences can inform our teaching. Presenters explore the potential of the learning sciences to advance the translational enterprise.

  • Broadly Engaged Teams Drive More Equitable and Translational Science (Virtual + In Person)

    Presenters: Marisha Palm, MSc, PhD; Thomas W. Concannon, PhD; Debra Lerner, MS, PhD

    DEI | Bringing together stakeholders with different, complementary expertise and a broad range of perspectives is important to the development of clinical and translational science. We use the term broadly engaged team science to refer to the powerful and synergistic activity of bringing multi-disciplinary research teams together with patients, community members, and healthcare professionals. This approach to team building and research conduct has the potential to support more equitable research that moves across the translational phases to have an impact on health.

    In this session we will discuss how the fields of team science and public engagement developed separately, with somewhat similar but functionally separate programs, policy, and supporting materials and structures. We will make clear, however, that underlying principles such as respect for diverse expertise, the importance of communication, and recognition of the bi-directional influences of science and society are essential to both fields. The transformational potential of broadly engaged team science is related to the openness of these research teams to listen to a range of voices that together shape relevant research questions, develop research design, and build a path to dissemination and implementation.

    Our book collected experiences of broadly engaged team science from across Tufts Clinical and Translational Science Institute, and considered how to support and develop this work. In our session, we will discuss what we learned and where we go next. We believe that the underlying principles and practical efforts of broadly engaged teams could have the potential to drive more equitable and impactful research by increasing the inclusivity and diversity of teams. In addition to supporting diversity, equity, and inclusion, broadly engaged teams can further translational efforts by holding a more expansive set of ideas, priorities, and goals that flow across the translational spectrum, and remind team members of the ultimate aim of impact on health.

11:00 AM - 12:00 PM
  • CR Forum Presents Broadly Engaged Team Science: Lessons Learned in Community Building (Virtual + In Person)

    Presenter: Harry P. Selker, MD, MSPH, Dean, Tufts Clinical and Translational Science Institute (CTSI), Tufts University; Sergio Aguilar-Gaxiola, MD, PhD, Director, Center for Reducing Health Disparities, University of California Davis

    CR Forum | Broadly-engaged team science is an important concept used in today's practice of clinical and translational research to address health disparities and health equity. One of the most challenging aspects is inclusion of diverse participants as equal members of the clinical research team. This panel will examine lessons learned, what worked and what has not worked, in achieving impactful research breakthroughs using an inclusive, broadly-engaged team science approach.

  • Developing a Clinical Research Investigator Training Program for New Investigators: Successes, Challenges, and Lessons Learned

    Presenter: Britta Magnuson, DMD; Kris M. Markman, PhD

    Translational Workforce Development + Education | This presentation will describe the creation and implementation of the Blue Star Investigator Certificate Program at Tufts CTSI, an eight-week learning experience aimed at developing junior investigators skills in running clinical trials and adhering to best practices for the conduct of quality research. The program was developed to address the need to create a pipeline for young clinicians to become principal investigators on studies than can impact translational research. The program follows a blended model, with asynchronous online pre-work introducing fundamental course concepts, combined with mixed didactic and hands-on exercises in weekly, two-hour synchronous sessions. Over the course of the eight-week program, learners are introduced to aspects of study development and conduct, beginning with protocol development and budgeting, followed by regulatory review, participant recruitment and stakeholder engagement, adverse event reporting and preparing for an audit, leading research teams, and study close-out procedures. For each session, local institutional content experts lead group exercises and provide additional context about investigator duties and responsibilities. Each session is also evaluated through pre- and post-test questionnaires assessing learner’s self-reported confidence in the core competencies associated with the session. After more than a year of planning and development, the Blue Star Program launched in September 2021 with a cohort of eleven investigators across several medical specialties. In this session, Blue Star team members Dr. Britta Magnuson, Associate Director for Regulatory Affairs, and Dr. Kris Markman, Director of Professional Education, will discuss the challenges and successes the team experienced in the design and dissemination of the program. In addition, Dr. Magnuson and Dr. Markman will reflect on lessons learned which may be generalizable to implementing similar investigator training programs at other clinical and translational science institutes.

  • Using Science and Evidence to Improve Wellbeing through the WISE Indiana State University Partnership

    Presenters: Sarah Wiehe, MD, MPH; Amy Gilbert, JD, MPH; Daniel Rusyniak, MD; Amber E. Osterholt, PhD

    Valued Approaches | WISE Indiana (Wellbeing Informed by Science and Evidence in Indiana) is a partnership between the Indiana Family and Social Services Administration (FSSA), the agency that administers Medicaid and other social services for the State of Indiana, and the Indiana Clinical and Translational Sciences Institute (I-CTSI), a Clinical and Translational Science Awards (CTSA) hub comprising Indiana University, the University of Notre Dame and Purdue University. The partnership was established to engage CTSI’s nationally recognized academic experts in a wide range of activities that inform FSSA practices, programs and policies.  New activities are initiated when the agency identifies a need for academic expertise and submits a task order request to the WISE Indiana team at I-CTSI. CTSAs in general are uniquely situated to participate in state university partnerships because of their collaborative networks and focus on translational research.  Indiana CTSI has been able to rapidly respond to FSSA’s task order requests by engaging experts through its well-established faculty relationships and robust community engagement network, including research navigators at each of its partner institutions. Examples of task orders from Indiana’s COVID-19 pandemic era will be described to help illustrate the task order process.  For example, the WISE Indiana COVID-19 Rapid Response Team project facilitated rapid, evidence-based responses to complex state questions and summarized the rapidly emerging scientific literature for state personnel, healthcare providers and systems, managed care entities, community organizations, and other front-line responders. The bidirectional exchange of information through I-CTSI has enabled the WISE Indiana team to quickly pivot and respond to the needs of FSSA. With help from the experts, WISE Indiana is capable of rapidly responding to the needs of the FSSA and serves as a model for other CTSA state university partnerships.

  • Incorporating Justice, Equity, Diversity, And Inclusion Across the Life Cycle of a Research Study (Virtual + In Person)

    Presenters: Jareen Meinzen-Derr, PhD; Shawnita Sealy-Jefferson, PhD; Eneida Mendonca, MD, PhD; Susan M. Perkins, Ph.D.

    DEI | In this session, a panel will discuss the key issues that need to be addressed in order to develop methodological best practices for incorporating justice, equity, diversity, and inclusion into the life cycle of a clinical research study. This would include the study design, data capture, analysis, and interpretation stages of a study. The longer term goal would be to develop working groups that will lead to the development and/or refinement of these best practices. 

12:00 - 1:30 PM Lunch
12:00 - 2:30 PM
  • Mock Study Section*

    Core Activities | This event is designed for trainees (pre- and post-doctoral) and junior faculty who are writing individual research fellowship (F), career development (K), and research (R01) grants. The objective is to educate early-stage investigators in the grant review process and to assist in making their grants more competitive in today’s funding climate.

    *This session requires pre-registration.

1:30 PM - 2:30 PM
  • CR Forum Industry Roundtable Part Two: The Ongoing Impact of COVID on Industry/Academic Center Partnerships

    Presenter: Anantha Shekhar, MD, PhD

    CR Forum | The rapid federal investment in COVID-related clinical research has helped develop large-scale industry and academic health center collaboration efforts for vaccine development and treatments. How are these collaborations among multiple academic centers and industry working out?  How are potential therapies identified and prioritized? How are these public/private partnerships decreasing timelines for the rapid testing of therapies? Physician scientists and senior faculty members from Vanderbilt Medical Center, Indiana University, University of Illinois Chicago and University of Pittsburgh share their experiences and perspectives.

    Moderator/Panel Organizer: Mark W. Geraci, MD, Associate Vice Chancellor for Interdisciplinary Research, Health Sciences, University of Pittsburgh

    Panelists:

    Gordon R. Bernard, MD; Executive Vice President for Research, Vanderbilt University Medical Center

    Sharon M. Moe, MD; Associate Dean for Clinical and Translational Research, Indiana University School of Medicine

    Jerry A. Krishnan, MD, PhD; Associate Vice Chancellor for Population Health Sciences, University of Illinois Chicago School of Public Health

     

  • Advancing Translational Science: Using Case Studies to Identify, Teach, and Disseminate Effective Approaches

    Presenters: Jessica M. Faupel-Badger, PhD MPH; Amanda L. Vogel, PhD MPH; Clara M. Pelfrey, PhD; Deborah DiazGranados, PhD; Emily Marti, MA

    Valued Approaches | This panel will share a variety of ways case studies are being used to advance translational science, via evaluation, education, and communications. This tried-and-true method for both evaluation and teaching uses in-depth analysis of a specific case to generate knowledge of complex phenomena and insights into how this knowledge can be applied in other contexts. In translational research, a case study typically examines a research initiative, its outcomes, and the multi-level interacting influences on these outcomes, to develop knowledge of key challenges and factors influencing success. In communications, case studies are used to effectively convey and enable retention of complex concepts via succinct, compelling, and relatable stories. In this session, panelists will describe how they effectively use case studies of translational research in each of these applications. They will share their philosophies, approaches, and methods, highlight relevant audiences, and provide outcomes and impacts to date. Panelists from CTSA hubs will highlight their evaluation work using retrospective case studies of effective translational research initiatives and cross-case comparisons to generate insights about effective translational research practices. CTSA panelists will also share how findings can be applied to help scientists anticipate challenges and identify potential solutions, and help institutions and funders better facilitate and support translation. Panelists from NCATS will highlight how NCATS uses the case study-based teaching approach to convey complex translational science concepts to students across training and career stages. They will also share their course design principles, outcomes, and impacts, as well as describe how NCATS uses case studies to develop generalizable translational science principles and communicate them via relatable stories that showcase how these principles advanced translation. At the end of this session, attendees will learn new ways case studies can support their work to identify and disseminate generalizable principles and practices that can be applied to improve the translational process.

  • Developing Competency-aligned Job Descriptions for Clinical Research Professionals (Virtual + In Person)

    Presenters: Anthony Keyes, MBA, PMP; Denise Snyder, MS, RD, LDN

    Translational Workforce Development + Education | Recently, much work has been done to develop competency-aligned job descriptions for clinical research professionals. In this session we will describe historical efforts, evaluate several current projects underway at Academic Medical Centers and outline collaborative efforts to share resources in developing and disseminating best practices.

  • Health Disparities: A Translational Research Approach Online Course Multi-institutional Experience (Virtual + In Person)

    Presenters: Lourdes E. Soto de Laurido Ed.D., MPHE

    DEI | In this session, attendees will hear from  eight cohorts of researchers from minority institutions to explore  general aspects of translational research in health disparities and evaluate the multi-level determinants to target appropriate solutions. 

2:30 - 2:45 PM Break
2:45 - 3:45 PM
3:45 - 4:00 PM Break
4:00 - 5:00 PM 
  • Plenary Presentation + CR Forum Top 10 Presentations (Virtual + In Person)

    Translational Science and Community Health: Impact and Implications

    Presenters:

    • Elizabeth Cohn, RN, PhD, Associate Provost for Research, Hunter College
    • Sergio Aguilar-Gaxiola, M.D., Ph.D. Director, UC Davis Center for Reducing Health Disparities
    • Muredach Reilly, MD, Director, CTSA Columbia University
    • Tabia Akintobi, PhD, MPH, Professor of Community Health and Preventive Medicine, Morehouse School of Medicine

    More details to be announced soon.

5:15 - 6:45 PM

*Activity and/or session requires pre-registration.

 

Tuesday, April 19

View the schedule of pre-meeting activities for Tuesday.

Wednesday, April 20

View the schedule of activities for Wednesday.

Friday, April 22

View the schedule of activities for Friday.

Co-Supported by:

Thank you to our sponsors:

Thank you to our travel sponsor:

Thank you to our 3MT award sponsor:

Search